Fabio
184 lines
13 KiB
Markdown
184 lines
13 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "DRUG TAKE-BACK ACT"
|
||
description: "Creates the Drug Take-Back Act. Requires covered manufacturers to, no later than July 1, 2022 or 6 months after becoming a covered manufacturer, whichever is later, participate in an approved drug take-back program or have established and implemented a drug take-back program independently or as part of a group of covered manufacturers. Provides requirements for the drug take-back program and for manufacturer program operators. Requires each manufacturer program operator to submit a proposal for the establishment and implementation of a drug take-back program to the Environmental Protection Agency for review and approval. Contains provisions regarding changes or modifications to drug take-back programs, promotion of drug take-back programs, annual reports, funding, and reimbursement. Requires covered manufacturers and manufacturer program operators to submit an annual $5,000 registration fee. Specifies civil penalties for violation of the Act. Preempts home rule powers. Contains other provisions. Amends the Freedom of Information Act. Provides that proprietary information submitted to the Environmental Protection Agency under the Drug Take-Back Act is exempt from inspection and copying under the Act. Effective immediately."
|
||
jurisdiction: "us/states/il"
|
||
legislature: "Illinois General Assembly"
|
||
session: "102nd"
|
||
identifier: "HB 1780"
|
||
citation: "Illinois HB 1780 (102nd)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["Jennifer Gong-Gershowitz", "Laura Fine"]
|
||
version_count: 8
|
||
action_count: 91
|
||
vote_count: 5
|
||
first_action: "2021-02-16"
|
||
last_action: "2022-06-10"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/6fdb6974-1464-437b-a80a-8c28f47a03e4"
|
||
source_url: "https://ilga.gov/legislation/BillStatus.asp?DocNum=1780&GAID=16&DocTypeID=HB&LegId=130486&SessionID=110&GA=102"
|
||
source_hash: "241ba6c2704bbd724797e718a2ee5642aecbd113623ebc15d56d328b34851d25"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-il"]
|
||
---
|
||
|
||
# Illinois HB 1780 (102nd) — DRUG TAKE-BACK ACT
|
||
|
||
Creates the Drug Take-Back Act. Requires covered manufacturers to, no later than July 1, 2022 or 6 months after becoming a covered manufacturer, whichever is later, participate in an approved drug take-back program or have established and implemented a drug take-back program independently or as part of a group of covered manufacturers. Provides requirements for the drug take-back program and for manufacturer program operators. Requires each manufacturer program operator to submit a proposal for the establishment and implementation of a drug take-back program to the Environmental Protection Agency for review and approval. Contains provisions regarding changes or modifications to drug take-back programs, promotion of drug take-back programs, annual reports, funding, and reimbursement. Requires covered manufacturers and manufacturer program operators to submit an annual $5,000 registration fee. Specifies civil penalties for violation of the Act. Preempts home rule powers. Contains other provisions. Amends the Freedom of Information Act. Provides that proprietary information submitted to the Environmental Protection Agency under the Drug Take-Back Act is exempt from inspection and copying under the Act. Effective immediately.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Introduced** (filed) — [source](https://ilga.gov/legislation/102/HB/PDF/10200HB1780.pdf)
|
||
2. **Engrossed** (committee substitute) — [source](https://ilga.gov/legislation/102/HB/PDF/10200HB1780eng.pdf)
|
||
3. **House Amendment 001** (committee substitute) — [source](https://ilga.gov/legislation/102/HB/PDF/10200HB1780ham001.pdf)
|
||
4. **House Amendment 002** (committee substitute) — [source](https://ilga.gov/legislation/102/HB/PDF/10200HB1780ham002.pdf)
|
||
5. **Senate Amendment 001** (committee substitute) — [source](https://ilga.gov/legislation/102/HB/PDF/10200HB1780sam001.pdf)
|
||
6. **Senate Amendment 002** (committee substitute) — [source](https://ilga.gov/legislation/102/HB/PDF/10200HB1780sam002.pdf)
|
||
7. **Senate Amendment 003** (committee substitute) — [source](https://ilga.gov/legislation/102/HB/PDF/10200HB1780sam003.pdf)
|
||
8. **Enrolled** (enrolled) — [source](https://ilga.gov/legislation/102/HB/PDF/10200HB1780enr.pdf)
|
||
|
||
## Votes
|
||
|
||
- Concurrence — **95–14** (pass) · lower
|
||
- Third Reading — **96–13** (pass) · lower
|
||
- Concurrence — **95–14** (pass) · lower
|
||
- Third Reading — **46–2** (pass) · upper
|
||
- Concurrence, Amendment 3 — **95–14** (pass) · lower
|
||
|
||
## Sponsors
|
||
|
||
- Jennifer Gong-Gershowitz — primary (person)
|
||
- Laura Fine — primary (person)
|
||
- Ann Gillespie — cosponsor (person)
|
||
- Ann M. Williams — cosponsor (person)
|
||
- Anne Stava-Murray — cosponsor (person)
|
||
- Anthony DeLuca — cosponsor (person)
|
||
- Antonio Muñoz — cosponsor (person)
|
||
- Dagmara Avelar — cosponsor (person)
|
||
- Deb Conroy — cosponsor (person)
|
||
- Jacqueline Y. Collins — cosponsor (person)
|
||
- Jaime M. Andrade, Jr. — cosponsor (person)
|
||
- Joyce Mason — cosponsor (person)
|
||
- Kambium Buckner — cosponsor (person)
|
||
- Kelly M. Cassidy — cosponsor (person)
|
||
- Laura Ellman — cosponsor (person)
|
||
- Lawrence Walsh, Jr. — cosponsor (person)
|
||
- Mark Luft — cosponsor (person)
|
||
- Martin McLaughlin — cosponsor (person)
|
||
- Michelle Mussman — cosponsor (person)
|
||
- Patricia Van Pelt — cosponsor (person)
|
||
- Robert Rita — cosponsor (person)
|
||
- Robyn Gabel — cosponsor (person)
|
||
- Ryan Spain — cosponsor (person)
|
||
- Sara Feigenholtz — cosponsor (person)
|
||
- Terra Costa Howard — cosponsor (person)
|
||
- Tom Demmer — cosponsor (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2021-02-16** Filed with the Clerk by Rep. Jennifer Gong-Gershowitz `filing`
|
||
- **2021-02-17** First Reading `reading-1`
|
||
- **2021-02-17** Referred to Rules Committee `referral-committee`
|
||
- **2021-02-24** Added Co-Sponsor Rep. Terra Costa Howard
|
||
- **2021-02-26** Added Co-Sponsor Rep. Anne Stava-Murray
|
||
- **2021-03-01** Added Co-Sponsor Rep. Kelly M. Cassidy
|
||
- **2021-03-09** Added Co-Sponsor Rep. Deb Conroy
|
||
- **2021-03-09** Assigned to Prescription Drug Affordability & Accessibility Committee `referral-committee`
|
||
- **2021-03-11** Added Co-Sponsor Rep. Kambium Buckner
|
||
- **2021-03-26** Added Chief Co-Sponsor Rep. Dagmara Avelar
|
||
- **2021-03-26** Added Co-Sponsor Rep. Michelle Mussman
|
||
- **2021-03-27** Rule 19(a) / Re-referred to Rules Committee `referral-committee`
|
||
- **2022-01-11** Assigned to Prescription Drug Affordability & Accessibility Committee `referral-committee`
|
||
- **2022-01-26** Added Chief Co-Sponsor Rep. Tom Demmer
|
||
- **2022-01-27** Added Co-Sponsor Rep. Robert Rita
|
||
- **2022-01-31** House Committee Amendment No. 1 Filed with Clerk by Rep. Jennifer Gong-Gershowitz `amendment-introduction`
|
||
- **2022-01-31** House Committee Amendment No. 1 Referred to Rules Committee `referral-committee`
|
||
- **2022-02-01** Added Co-Sponsor Rep. Ryan Spain
|
||
- **2022-02-02** Added Co-Sponsor Rep. Robyn Gabel
|
||
- **2022-02-03** Added Co-Sponsor Rep. Ann M. Williams
|
||
- **2022-02-07** Added Co-Sponsor Rep. Lawrence Walsh, Jr.
|
||
- **2022-02-07** Added Co-Sponsor Rep. Anthony DeLuca
|
||
- **2022-02-08** House Committee Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee
|
||
- **2022-02-09** House Committee Amendment No. 1 Adopted in Prescription Drug Affordability & Accessibility Committee; by Voice Vote `amendment-passage`
|
||
- **2022-02-09** Do Pass as Amended / Short Debate Prescription Drug Affordability & Accessibility Committee; 015-002-000 `committee-passage`
|
||
- **2022-02-09** Added Co-Sponsor Rep. Martin McLaughlin
|
||
- **2022-02-10** Added Co-Sponsor Rep. Joyce Mason
|
||
- **2022-02-10** Added Co-Sponsor Rep. Mark Luft
|
||
- **2022-02-15** Placed on Calendar 2nd Reading - Short Debate
|
||
- **2022-02-15** Added Co-Sponsor Rep. Jaime M. Andrade, Jr.
|
||
- **2022-02-16** House Floor Amendment No. 2 Filed with Clerk by Rep. Jennifer Gong-Gershowitz `amendment-introduction`
|
||
- **2022-02-16** House Floor Amendment No. 2 Referred to Rules Committee `referral-committee`
|
||
- **2022-02-17** House Floor Amendment No. 2 Recommends Be Adopted Rules Committee; 004-000-000 `committee-passage-favorable`
|
||
- **2022-02-22** Second Reading - Short Debate `reading-2`
|
||
- **2022-02-22** House Floor Amendment No. 2 Adopted `amendment-passage`
|
||
- **2022-02-22** Placed on Calendar Order of 3rd Reading - Short Debate
|
||
- **2022-02-23** Third Reading - Short Debate - Passed 096-013-000 `passage, reading-3`
|
||
- **2022-02-23** Arrive in Senate `introduction`
|
||
- **2022-02-23** Placed on Calendar Order of First Reading `reading-1`
|
||
- **2022-02-23** Chief Senate Sponsor Sen. Laura Fine
|
||
- **2022-02-23** Added as Alternate Chief Co-Sponsor Sen. Antonio Muñoz
|
||
- **2022-02-23** First Reading `reading-1`
|
||
- **2022-02-23** Referred to Assignments `referral-committee`
|
||
- **2022-03-02** Assigned to Executive `referral-committee`
|
||
- **2022-03-16** Senate Committee Amendment No. 1 Filed with Secretary by Sen. Laura Fine `amendment-introduction`
|
||
- **2022-03-16** Senate Committee Amendment No. 1 Referred to Assignments `referral-committee`
|
||
- **2022-03-18** Senate Committee Amendment No. 2 Filed with Secretary by Sen. Laura Fine `amendment-introduction`
|
||
- **2022-03-18** Senate Committee Amendment No. 2 Referred to Assignments `referral-committee`
|
||
- **2022-03-22** Senate Committee Amendment No. 1 Assignments Refers to Executive
|
||
- **2022-03-22** Senate Committee Amendment No. 2 Assignments Refers to Executive
|
||
- **2022-03-23** Senate Committee Amendment No. 1 Adopted `amendment-passage`
|
||
- **2022-03-23** Senate Committee Amendment No. 2 Adopted `amendment-passage`
|
||
- **2022-03-23** Do Pass as Amended Executive; 016-000-000 `committee-passage`
|
||
- **2022-03-23** Placed on Calendar Order of 2nd Reading
|
||
- **2022-03-23** Second Reading `reading-2`
|
||
- **2022-03-23** Placed on Calendar Order of 3rd Reading March 24, 2022
|
||
- **2022-03-25** Senate Floor Amendment No. 3 Filed with Secretary by Sen. Laura Fine `amendment-introduction`
|
||
- **2022-03-25** Senate Floor Amendment No. 3 Referred to Assignments `referral-committee`
|
||
- **2022-03-28** Senate Floor Amendment No. 3 Assignments Refers to Executive
|
||
- **2022-03-30** Senate Floor Amendment No. 3 Recommend Do Adopt Executive; 015-000-000
|
||
- **2022-03-31** Added as Alternate Co-Sponsor Sen. Ann Gillespie
|
||
- **2022-03-31** Added as Alternate Chief Co-Sponsor Sen. Sara Feigenholtz
|
||
- **2022-03-31** Added as Alternate Chief Co-Sponsor Sen. Patricia Van Pelt
|
||
- **2022-03-31** Added as Alternate Co-Sponsor Sen. Laura Ellman
|
||
- **2022-03-31** Recalled to Second Reading `reading-2`
|
||
- **2022-03-31** Senate Floor Amendment No. 3 Adopted; Fine `amendment-passage`
|
||
- **2022-03-31** Placed on Calendar Order of 3rd Reading
|
||
- **2022-03-31** Third Reading - Passed; 046-002-000 `passage, reading-3`
|
||
- **2022-03-31** Arrived in House `introduction`
|
||
- **2022-03-31** Placed on Calendar Order of Concurrence Senate Amendment(s) 1, 2, 3
|
||
- **2022-04-01** Senate Committee Amendment No. 1 Motion Filed Concur Rep. Jennifer Gong-Gershowitz
|
||
- **2022-04-01** Senate Committee Amendment No. 2 Motion Filed Concur Rep. Jennifer Gong-Gershowitz
|
||
- **2022-04-01** Senate Floor Amendment No. 3 Motion Filed Concur Rep. Jennifer Gong-Gershowitz
|
||
- **2022-04-01** Senate Committee Amendment No. 1 Motion to Concur Referred to Rules Committee `referral-committee`
|
||
- **2022-04-01** Senate Committee Amendment No. 2 Motion to Concur Referred to Rules Committee `referral-committee`
|
||
- **2022-04-01** Senate Floor Amendment No. 3 Motion to Concur Referred to Rules Committee `referral-committee`
|
||
- **2022-04-06** Senate Committee Amendment No. 1 Motion to Concur Recommends Be Adopted Rules Committee; 003-001-000
|
||
- **2022-04-06** Senate Committee Amendment No. 2 Motion to Concur Recommends Be Adopted Rules Committee; 003-001-000
|
||
- **2022-04-06** Senate Floor Amendment No. 3 Motion to Concur Recommends Be Adopted Rules Committee; 003-001-000
|
||
- **2022-04-07** Senate Committee Amendment No. 1 House Concurs 095-014-000
|
||
- **2022-04-07** Senate Committee Amendment No. 2 House Concurs 095-014-000
|
||
- **2022-04-07** Senate Floor Amendment No. 3 House Concurs 095-014-000
|
||
- **2022-04-07** House Concurs
|
||
- **2022-04-07** Motion Filed to Reconsider Vote Rep. Daniel Didech
|
||
- **2022-04-13** Motion to Reconsider Vote - Withdrawn Rep. Daniel Didech
|
||
- **2022-04-13** Passed Both Houses
|
||
- **2022-04-22** Added as Alternate Co-Sponsor Sen. Jacqueline Y. Collins
|
||
- **2022-05-12** Sent to the Governor `executive-receipt`
|
||
- **2022-06-10** Governor Approved `executive-signature`
|
||
- **2022-06-10** Effective Date June 10, 2022
|
||
- **2022-06-10** Public Act . . . . . . . . . 102-1055 `became-law`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/6fdb6974-1464-437b-a80a-8c28f47a03e4`. Confidence: reported (aggregated from official Illinois legislature records).
|
||
|